Prestige Biologics Co., Ltd.
Research Prestige Biologics Co., Ltd. (334970.KQ) on Bullrun: market cap KRW 103.10B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker334970.KQ
- ExchangeKQ
- CurrencyKRW
- Market capKRW 103.10B
- Financial periodQ1 2026
- RevenueKRW 2.27B
- Net income-KRW 14.65B
- Free cash flowKRW 603.55M
- Gross margin-411.9%
Valuation Snapshot
latest market cap is KRW 103.10B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | KRW 19.24B | -KRW 28.23B | -KRW 5.70B | -51.7% | n/a | KRW 563.06M | KRW 83.93B | KRW 113.99B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 103.10B | n/a | n/a | n/a |
Related stock research
Frequently asked questions
What is Prestige Biologics Co., Ltd.'s market cap?
Prestige Biologics Co., Ltd.'s market capitalization is KRW 103.10B.